Helicobacter Pylori
Copyright ©The Author(s) 2005. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 21, 2005; 11(27): 4140-4147
Published online Jul 21, 2005. doi: 10.3748/wjg.v11.i27.4140
Gastrin and antral G cells in course of Helicobacter pylori eradication: Six months follow up study
Aleksandra Sokic-Milutinovic, Vera Todorovic, Tomica Milosavljevic, Marjan Micev, Neda Drndarevic, Olivera Mitrovic
Aleksandra Sokic-Milutinovic, Tomica Milosavljevic, Clinic for Gastroenterology and Hepatology, Institute for Digestive Diseases, Clinical Center of Serbia, Serbia and Montenegro
Vera Todorovic, Neda Drndarevic, Olivera Mitrovic, Department of Imunohistochemistry and Electron Microscopy, Institute for Medical Research, Belgrade, Serbia and Montenegro
Marjan Micev, Pathology Department, Institute for Digestive Diseases, Clinical Center of Serbia, Serbia and Montenegro
Author contributions: All authors contributed equally to the work.
Supported by a Grant From Serbian Ministry for Science, Technology and Development, No. 1752
Correspondence to: Aleksandra Sokic-Milutinovic, MD, MSc, Clinical Center of Serbia, Clinic for Gastroenterology and Hepatology, Koste Todorovica 6, Belgrade 11000, Serbia and Montenegro. asokic2002@yahoo.com
Telephone: +381-11-3617777-3734 Fax: +381-11-361-5432
Received: October 13, 2004
Revised: November 20, 2004
Accepted: November 23, 2004
Published online: July 21, 2005
Abstract

AIM: To assess long-term effects of Helicobacter pylori (H pylori) eradication on antral G cell morphology and function in patients with and without duodenal ulcer (DU).

METHODS: Consecutive dyspeptic patients referred to the endoscopy entered the study. Out of 39 H pylori positive patients, 8 had DU (H pylori +DU) and 31 gastritis (H pylori +G). Control groups consisted of 11 uninfected dyspeptic patients (CG1) and 7 healthy volunteers (CG2). Basal plasma gastrin (PGL), antral tissue gastrin concentrations (ATGC), immunohistochemical and electron microscopic characteristics of G cells were determined, prior to and 6 mo after therapy.

RESULTS: We demonstrated elevated PGL in infected patients compared to uninfected controls prior to therapy. Elevated PGL were registered in all H pylori+patients (H pylori +DU: 106.78 ± 22.72 pg/mL, H pylori +G: 74.95 ± 15.63, CG1: 68.59 ± 17.97, CG2: 39.24 ± 5.59 pg/mL, P < 0.01). Successful eradication (e) therapy in H pylori+patients lead to significant decrease in PGL (H pylori+DU: 59.93 ± 9.40 and H pylori +Ge: 42.36 ± 10.28 pg/mL, P < 0.001). ATGC at the beginning of the study were similar in infected and uninfected patients and eradication therapy lead to significant decrease in ATGC in H pylori +gastritis, but not in DU patients. In the H pylori +DU patients, the mean number of antral G cells was significantly lower in comparison with all other groups (P < 0.01), but after successful eradication was close to normal values found in controls. By contrast, G cell number and volume density were significantly decreased (P < 0.01) in H pylori +Ge group after successful eradication therapy (294 ± 32 and 0.31 ± 0.02, respectively), in comparison to values before eradication (416 ± 40 and 0.48 ± 0.09). No significant change of the G cell/total endocrine cell ratio was observed during the 6 mo of follow up in any of the groups. A reversible increase in G cell secretory function was seen in all infected individuals, demonstrated by a more prominent secretory apparatus. However, differences between DU and gastritis group were identified.

CONCLUSION: H pylori infection induces antral G cell hyperfunction resulting in increased gastrin synthesis and secretion. After eradication therapy complete morphological and functional recovery is observed in patients with gastritis. In the DU patients some other factors unrelated to the H pylori infection influence antral G cell morphology and function.

Keywords: Gastrin, G cell, Duodenal ulcer, Gastritis, Helicobacter pylori